LongevityBank is a wholly owned subsidiary of CytoMed Therapeutics, offering comprehensive cell banking solutions to support long-term health, research, and future therapeutic applications.
Our services include cord blood banking, immune cell banking, and induced pluripotent stem cell (iPSC) banking, providing customers with secure, high-quality biological assets preserved to internationally recognised standards.
Through LongevityBank, CytoMed extends its commitment to building an integrated, future-ready cell ecosystem, empowering customers with access to advanced cell technologies for longevity and regenerative medicine.
Visit LongevityBank here